510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2952-2018Class II

Verigene Enteric Pathogens Nucleic Acid Test (EP) for detecting and identification of pathogenic enteric...

Luminex Corporation / initiated 2018-05-08 / Terminated

Luminex Corporation began a recall of Verigene Enteric Pathogens Nucleic Acid Test (EP) for detecting and identification of pathogenic enteric bacteria, viruses, and genetic virulence markers from... on . FDA classified it as Class II and gives the reason as "Elevated false positive results Yersinia enterocolitica (Yersinia) from customers using the EP Nucleic Acid Test Cartridges component (20-006-023) from the Verigene EP Nucleic Acid Test Kit (20-005-023)". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2952-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Luminex Corporation
Product
Verigene Enteric Pathogens Nucleic Acid Test (EP) for detecting and identification of pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
Product code
PCH Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
Reason for recall
Elevated false positive results Yersinia enterocolitica (Yersinia) from customers using the EP Nucleic Acid Test Cartridges component (20-006-023) from the Verigene EP Nucleic Acid Test Kit (20-005-023).
FDA root cause
Under Investigation by firm
Action
The firm notified customers on or about 05/08/2018 via a letter entitled "URGENT: MEDICAL DEVICE RECALL". The Luminex informed the customer reason why they are receiving a recall notice---elevated false positive Yersinia enterocolitica (Yersinia) results when using the EP Nucleic Acid Test Cartridges component (20-006-023) from the Verigene EP Nucleic Acid Test Kit (20-005-023). The letter described the intended use of the test kit and the distribution dates. The letter provided instructions for destroying the product if found in the inventory by a customer at a customer site. Luminex advised the customer to complete and return an enclosed Acknowledgment and Receipt form whether a customer had a recalled product on site or not. Luminex Technical Support are available assist in completing this form. Luminex Customer Experience Team contact information is as follows: 1-877-785-2323 (U.S. and Canada) (24 hours/7days) +1-512-381-4397 (Outside U.S. and Canada) (24 hours/7days) [email protected]
Quantity in commerce
790 Cartridge Carriers containing 3160 Cartridges
Distribution
Domestic Distribution: Arizona, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, New Hampshire, Tennessee, Texas, Utah, West Virginia, Wisconsin.
Product codes and lots
Catalog number 20-005-023;  Cartridge Catalog number 20-006-023;  Lot 032718023A;  UDI 00857573006041

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2952-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2952-2018Class IITerminatedVoluntary: Firm initiated